Network origin in Julie Illo Molin first degree
Entity | Entity type | Industry | |
---|---|---|---|
StemCare A/S
StemCare A/S BiotechnologyHealth Technology StemCare A/S operates as a private stem cell bank. The firm stores stem cells from umbilical cord blood. The company was founded by Sten Verland in 2003 and is headquartered in Gentofte, Denmark.
6
| Subsidiary | Biotechnology | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Julie Illo Molin via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
NTG NORDIC TRANSPORT GROUP A/S | Trucking | Public Communications Contact | |
Sjælsø Gruppen A/S
Sjælsø Gruppen A/S Financial ConglomeratesFinance Sjælsø Gruppen A/S engages in the trade and investment activities related to real estate. The firm develops real estate properties and also leases businesses, retail, and residential projects for owners, tenants, and investors. The company was founded by Ib Henrik Ronje and Torben Ronje on October 1, 1977 and is headquartered in Allerød, Denmark. | Financial Conglomerates | Director/Board Member | |
Astion Pharma A/S
Astion Pharma A/S Pharmaceuticals: MajorHealth Technology Astion Pharma A/S develops and manufactures pharmaceutical products. It focuses on developing anti-inflammatory drugs for dermatological and immunological diseases. The company was founded by Morten S. Weidner in 1992 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director of Finance/CFO | |
Synexus Compass, Inc.
Synexus Compass, Inc. Medical/Nursing ServicesHealth Services Synexus Compass, Inc. provided medical image-analysis, subject-recruitment and biochemical marker services that enable life-science industry clients to execute clinical trials while decreasing the time, uncertainty and cost of product development. The company was founded in 1998 and was headquartered in San Francisco, CA. | Medical/Nursing Services | Corporate Officer/Principal | |
Danish Venture Capital & Private Equity Association
Danish Venture Capital & Private Equity Association Investment ManagersFinance The Danish Venture Capital & Private Equity Association is an organization that represents business owners who are members of the association. The private company is based in Copenhagen, Denmark. The Danish company has recently released their annual activity report for the entire ecosystem of active ownership. The report can be downloaded from their website. Additionally, they have listed six specific wishes for political party leaders on their website. and has subsidiaries in Denmark. | Investment Managers | Director/Board Member | |
Danmarks Eksport- og Investeringsfond
Danmarks Eksport- og Investeringsfond Investment ManagersFinance Danmarks Eksport- og Investeringsfond (EIFO) is a venture capital subsidiary of Government of Denmark and founded in 1992. The firm is headquartered in Hellerup, Denmark. | Investment Managers | Private Equity Investor | |
M&B AS
M&B AS Agricultural Commodities/MillingProcess Industries Part of Taconic Biosciences, Inc., M&B AS breeds laboratory mice and rats for the scientific community. The company is based in Ry, Denmark. M&B was acquired by Taconic Biosciences, Inc. on May 01, 2002. | Agricultural Commodities/Milling | Chief Executive Officer | |
Copenhagen Business School | College/University | Graduate Degree | |
The University of Wales | College/University | Doctorate Degree | |
University of Copenhagen | College/University | Doctorate Degree Doctorate Degree | |
Scandinavian International Management Institute | College/University | Masters Business Admin | |
Center For Clinical & Basic Research
Center For Clinical & Basic Research Miscellaneous Commercial ServicesCommercial Services Part of Thermo Fisher Scientific, Inc., Center For Clinical & Basic Research is a Danish company that provides radiology services. The company is based in Ballerup, Denmark. The company was founded by Claus Henrik Christiansen. Center For Clinical & Basic Research was acquired by Synexus Compass, Inc., part of Thermo Fisher Scientific, Inc. from September 03, 2019 on July 14, 2006. | Miscellaneous Commercial Services | Chief Executive Officer | |
Sophion Bioscience A/S
Sophion Bioscience A/S Medical SpecialtiesHealth Technology Sophion Bioscience A/S develops, manufactures and markets instruments and supplies automated patch clamping. It develops throughput patch clamp solutions for functional characterization of living cells. The firm products are used in pharmaceutical and biotech companies around the world. The company was founded in July 2007 and is headquartered in Ballerup, Denmark. | Medical Specialties | Director/Board Member | |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Sunstone Capital A/S
Sunstone Capital A/S Investment ManagersFinance Sunstone Capital A/S (Sunstone) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was founded in 2007 by Peter Benson, Sten Verland, and Søren Lemonius, and invests on behalf of a group of institutional investors. | Investment Managers | Founder | |
Verland Capital ApS
Verland Capital ApS Investment ManagersFinance Verland Capital ApS (Verland Capital) is an independent venture capital firm headquartered in Bagsværd, Denmark. The firm was founded in 1994 by Sten Verland. | Investment Managers | Chief Executive Officer | |
OxThera AB
OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Director/Board Member | |
WNTRESEARCH AB | Pharmaceuticals: Other | Chief Executive Officer | |
Hartmanns A/S
Hartmanns A/S Personnel ServicesCommercial Services Hartmanns A/S produces molded fiber packaging. The company is headquartered in Ballerup, Denmark. | Personnel Services | Director/Board Member | |
Zymenex Holding A/S
Zymenex Holding A/S BiotechnologyHealth Technology Zymenex Holding A/S engages in the research and development of therapeutics for life threatening diseases. The company is headquartered in Hillerod, Denmark. | Biotechnology | Chairman | |
Anergis SA
Anergis SA Pharmaceuticals: GenericHealth Technology Anergis SA develops allergy vaccines. It is a biopharmaceutical company specializing in the discovery and development of novel, proprietary allergy vaccines that target commercially attractive indications and the firm’s vaccines are based on its IP-protected Contiguous Overlapping Peptide technology.The company was founded by Francois Spertini in August 2001 and is headquartered in Epalinges, Switzerland. | Pharmaceuticals: Generic | Director/Board Member | |
Acesion Pharma ApS
Acesion Pharma ApS Pharmaceuticals: MajorHealth Technology Acesion Pharma ApS develops drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. The firm's technology blocks ion channel with a selective drug molecule constitutes a target for developing treatment of AF. The company was founded by Ulrik Svane S?rensen and Morten Grunnet in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director of Finance/CFO | |
Dermaveris ApS | Chairman | ||
StemCare Danmark A/S | Director/Board Member | ||
Skovlyst Production A/S
Skovlyst Production A/S Beverages: AlcoholicConsumer Non-Durables Skovlyst Production A/S operates a brewery restaurant. It serves a hand-brewed beer from elderflower, birch sap, beech twigs, woodruff, and nettles. The firm also offers a combined picnic with beer tasting. The company was founded by Casper Mikkel Møller on February 21, 2007 and is headquartered in Birkerød, Denmark. | Beverages: Alcoholic | Director/Board Member | |
Rigontec GmbH
Rigontec GmbH Pharmaceuticals: MajorHealth Technology Rigontec GmbH provides RNA-based immunotherapeutics for the treatment of cancer and viral diseases. The firm develops a compound stimulating the immune receptor retinoic acid-inducible gene. The company was founded by Annegret de Baey-Diepolder, Gunther Hartmann, Anna Schwickart, Marcel Renn, Christine Schuberth-Wagner and Veit Hornung in 2014 and is headquartered in Munich, Germany. | Pharmaceuticals: Major | Director/Board Member | |
Demetech AB | Director/Board Member | ||
Verland Holding ApS | Corporate Officer/Principal | ||
INITIATOR PHARMA A/S | Pharmaceuticals: Major | Director/Board Member | |
Werner Richter Og Hustrus Legat | Chairman | ||
Tera Holding A/S
Tera Holding A/S Real Estate DevelopmentFinance Tera Holding A/S provides commercial property rental services. The private company is based in Karlslunde, Denmark. | Real Estate Development | Director/Board Member | |
Vetverland ApS | Chief Executive Officer | ||
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Pharmaceuticals: Major | Director of Finance/CFO | |
FLUOGUIDE A/S | Pharmaceuticals: Major | Director of Finance/CFO | |
STipe Therapeutics ApS
STipe Therapeutics ApS Pharmaceuticals: MajorHealth Technology STipe Therapeutics ApS operates as a biotechnology company. It specializes in the immune-oncology field, pioneer therapies using a novel aspect of the stimulator of interferon genes (STING) Pathway to target cancer. The company was founded in 2018 and is headquartered in Denmark. | Pharmaceuticals: Major | Director/Board Member | |
BIOSERGEN AB | Biotechnology | Director/Board Member | |
Vaximm AG
Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Miscellaneous Commercial Services | Director/Board Member |
Statistics
International
Denmark | 37 |
Sweden | 8 |
United Kingdom | 3 |
Germany | 3 |
Switzerland | 3 |
Sectoral
Health Technology | 24 |
Finance | 8 |
Commercial Services | 6 |
Consumer Services | 5 |
Transportation | 2 |
Operational
Director/Board Member | 34 |
Chairman | 9 |
Chief Executive Officer | 7 |
Director of Finance/CFO | 5 |
Corporate Officer/Principal | 4 |
Most connected contacts
- Stock Market
- Insiders
- Julie Illo Molin
- Company connections